An anticancer therapy-elicited immunosurveillance system that eliminates tetraploid cells

OncoImmunology

Volumn 2, Issue 1, 2013, Pages

  Senovilla, Laura ^a,b,c   Vitale, Ilio ^a,b,c   Martins, Isabelle ^a,b,c   Kepp, Oliver ^a,b,c   Galluzzi, Lorenzo ^b,d   Zitvoge, Laurence ^b,c,e   Castedo, Maria ^a,b,c   Kroemer, Guido ^a,b,d,f,g  

^a Institut Gustave Roussy   (France)

^b INSTITUT GUSTAVE ROUSSY   (France)

^c UNIVERSITÉ PARIS SACLAY   (France)

^d UNIVERSITÉ PARIS DESCARTES   (France)

^e University Paris XI   (France)

^f CENTRE DE RECHERCHE DES CORDELIERS   (France)

^g HÔPITAL EUROPÉEN GEORGES POMPIDOU   (France)

Author keywords

Breast carcinoma; Calreticulin; HMGB1; Hyperploidy; Immunogenic cell death; Mitotic catastrophe

Indexed keywords

3 METHYLCHOLANTHRENE; ANTHRACYCLINE; ANTINEOPLASTIC AGENT; CELL NUCLEUS DNA; DOCETAXEL; EPOTHILONE B; HIGH MOBILITY GROUP B1 PROTEIN; MEDROXYPROGESTERONE; OXALIPLATIN; PACLITAXEL; PROTEIN P53; RETINOBLASTOMA PROTEIN; TRANSCRIPTION FACTOR FOXP3; VINBLASTINE; VINCRISTINE;

ARTICLE; B CELL LYMPHOMA; BREAST CANCER; CANCER ADJUVANT THERAPY; CANCER PROGNOSIS; CANCER THERAPY; CARCINOGENESIS; CD8+ T LYMPHOCYTE; CELL FUSION; CELL PROLIFERATION; CELL SURVIVAL; CHROMOSOME NUMBER; CYTOKINESIS; DNA REPLICATION; DRUG RESPONSE; ENDOPLASMIC RETICULUM STRESS; FIBROSARCOMA; GENETIC HETEROGENEITY; HUMAN; IMMUNE RESPONSE; IMMUNOCOMPROMISED PATIENT; IMMUNOSURVEILLANCE; LEWIS CARCINOMA; MALIGNANT TRANSFORMATION; MITOSIS; MULTIPLE CYCLE TREATMENT; NONHUMAN; NUCLEAR SIZE; ONCOGENE MYC; POLYPLOIDY; PRIORITY JOURNAL; TETRAPLOIDY;

EID: 84880732251     PISSN: 21624011     EISSN: 2162402X     Source Type: Journal    
DOI: 10.4161/onco.22409     Document Type: Article

References (13)

1. Davoli T, de Lange T. The causes and consequences of polyploidy in normal development and cancer. Annu Rev Cell Dev Biol 2011, 27:585-610, PMID:21801013, http://dx.doi.org/10.1146/annurevcellbio-092910-154234.
2. Ganem NJ, Storchova Z, Pellman D. Tetraploidy, aneuploidy and cancer. Curr Opin Genet Dev 2007, 17:157-62, PMID:17324569, http://dx.doi. org/10.1016/j.gde.2007.02.011.
3. Fujiwara T, Bandi M, Nitta M, Ivanova EV, Bronson RT, Pellman D. Cytokinesis failure generating tetraploids promotes tumorigenesis in p53-null cells. Nature 2005, 437:1043-7, PMID:16222300, http://dx.doi. org/10.1038/nature04217.
4. Vitale I, Galluzzi L, Castedo M, Kroemer G. Mitotic catastrophe: a mechanism for avoiding genomic instability. Nat Rev Mol Cell Biol 2011, 12:385-92, PMID:21527953, http://dx.doi.org/10.1038/ nrm3115.
5. Vitale I, Galluzzi L, Senovilla L, Criollo A, Jemaà M, Castedo M, et al. Illicit survival of cancer cells during polyploidization and depolyploidization. Cell Death Differ 2011, 18:1403-13, PMID:21072053, http:// dx.doi.org/10.1038/cdd.2010.145.
6. Senovilla L, Vitale I, Martins I, Tailler M, Pailleret C, Michaud M, et al. An immunosurveillance mechanism controls cancer cell ploidy. Science 2012, 337:1678-84, PMID:23019653, http://dx.doi.org/10.1126/science. 1224922.
7. Obeid M, Tesniere A, Ghiringhelli F, Fimia GM, Apetoh L, Perfettini JL, et al. Calreticulin exposure dictates the immunogenicity of cancer cell death. Nat Med 2007, 13:54-61, PMID:17187072, http://dx.doi. org/10.1038/nm1523.
8. Panaretakis T, Kepp O, Brockmeier U, Tesniere A, Bjorklund AC, Chapman DC, et al. Mechanisms of pre-apoptotic calreticulin exposure in immunogenic cell death. EMBO J 2009, 28:578-90, PMID:19165151, http://dx.doi.org/10.1038/emboj.2009.1.
9. Apetoh L, Ghiringhelli F, Tesniere A, Obeid M, Ortiz C, Criollo A, et al. Toll-like receptor 4-dependent contribution of the immune system to anticancer chemotherapy and radiotherapy. Nat Med 2007, 13:1050-9, PMID:17704786, http://dx.doi.org/10.1038/nm1622
10. Ghiringhelli F, Apetoh L, Tesniere A, Aymeric L, Ma Y, Ortiz C, et al. Activation of the NLRP3 inflammasome in dendritic cells induces IL-1beta-dependent adaptive immunity against tumors. Nat Med 2009, 15:1170-8, PMID:19767732, http://dx.doi.org/10.1038/nm.2028.
11. Michaud M, Martins I, Sukkurwala AQ, Adjemian S, Ma Y, Pellegatti P, et al. Autophagy-dependent anticancer immune responses induced by chemotherapeutic agents in mice. Science 2011, 334:1573-7, PMID:22174255, http://dx.doi.org/10.1126/science. 1208347.
12. Galluzzi L, Senovilla L, Zitvogel L, Kroemer G. The secret ally: immunostimulation by anticancer drugs. Nat Rev Drug Discov 2012, 11:215-33, PMID:22301798, http://dx.doi.org/10.1038/nrd3626.
13. Ladoire S, Mignot G, Dabakuyo S, Arnould L, Apetoh L, Rébé C, et al. In situ immune response after neoadjuvant chemotherapy for breast cancer predicts survival. J Pathol 2011, 224:389-400, PMID:21437909, http:// dx.doi.org/10.1002/path.2866.